ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,567.19
1.06%
US Tech 100
19,827.20
0.94%
Dow Jones
39,375.87
0.17%
Brent Oil
86.775
0.00%
Bitcoin
56,386.03
-0.46%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. AnaptysBio Inc (ANAB)

  7. AnaptysBio Inc (ANAB) News

ANAB

AnaptysBio (ANAB)

AnaptysBio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ANAB
DateTimeSourceHeadlineSymbolCompany
11/15/20217:24PMGlobeNewswire Inc.AnaptysBio To Present at the 2021 Jefferies London Healthcare ConferenceNASDAQ:ANABAnaptysBio Inc
11/15/20219:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
11/15/20219:00AMGlobeNewswire Inc.AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line DataNASDAQ:ANABAnaptysBio Inc
11/05/20216:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
11/05/20216:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
11/04/20214:20PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANABAnaptysBio Inc
11/04/20214:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
11/04/20214:05PMGlobeNewswire Inc.AnaptysBio Announces Third Quarter 2021 Financial Results and Provides Pipeline UpdatesNASDAQ:ANABAnaptysBio Inc
11/02/20215:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
10/28/20217:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
10/25/20214:47PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
10/25/20214:37PMGlobeNewswire Inc.AnaptysBio Announces Agreement to Monetize Portion of JEMPERLI Royalties for $250 Million with SagardNASDAQ:ANABAnaptysBio Inc
10/02/202112:00PMGlobeNewswire Inc.AnaptysBio Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in Generalized Pustular PsoriasisNASDAQ:ANABAnaptysBio Inc
09/21/20215:39PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
09/09/20214:05PMGlobeNewswire Inc.AnaptysBio to Participate in the H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:ANABAnaptysBio Inc
08/17/20216:50PMDow Jones NewsAnaptysBio Up 10% on GSK Drug Indication ApprovalNASDAQ:ANABAnaptysBio Inc
08/17/20214:32PMGlobeNewswire Inc.FDA Grants Accelerated Approval of JEMPERLI (dostarlimab-gxly) for dMMR Recurrent or Advanced Solid TumorsNASDAQ:ANABAnaptysBio Inc
08/09/20214:15PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANABAnaptysBio Inc
08/09/20214:05PMGlobeNewswire Inc.AnaptysBio Announces Second Quarter 2021 Financial Results and Provides Pipeline UpdatesNASDAQ:ANABAnaptysBio Inc
06/17/20215:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ANABAnaptysBio Inc
05/27/20214:15PMGlobeNewswire Inc.AnaptysBio to Present at the 2021 Jefferies Virtual Healthcare ConferenceNASDAQ:ANABAnaptysBio Inc
05/04/20214:52PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ANABAnaptysBio Inc
05/04/20214:24PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ANABAnaptysBio Inc
05/04/20214:05PMGlobeNewswire Inc.AnaptysBio Announces First Quarter 2021 Financial Results and Provides Pipeline UpdatesNASDAQ:ANABAnaptysBio Inc
04/26/20214:02PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ANABAnaptysBio Inc
04/26/20214:01PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ANABAnaptysBio Inc
04/23/202112:06PMDow Jones NewsAnaptysBio Says EC Approval of Jemperli Triggers Milestone PaymentNASDAQ:ANABAnaptysBio Inc
04/23/202110:31AMGlobeNewswire Inc.European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MS...NASDAQ:ANABAnaptysBio Inc
04/22/20215:19PMDow Jones NewsAnaptysBio Says JEMPERLI Drug Gets FDA ApprovalNASDAQ:ANABAnaptysBio Inc
04/22/20214:12PMGlobeNewswire Inc.FDA Approves JEMPERLI (dostarlimab-gxly) for dMMR Endometrial CancerNASDAQ:ANABAnaptysBio Inc
 Showing the most relevant articles for your search:NASDAQ:ANAB

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
NASDAQ
NVDA
NVIDIA
COIN
SHIBUSD
SHIBA INU
USOTC
SPZI
Spooz (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
TSLA
Tesla
USOTC
PSRU
Valiant Eagle (PK)
AMEX
SPY
SPDR S&P 500
USOTC
ENZC
Enzolytics (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
ERHE
ERHC Energy (CE)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
CLNV
Clean Vision (QB)
COIN
BTCUSD
Bitcoin
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved